[1]
Karaźniewicz-Łada, M. et al. 2014. The influence of diabetic status on the pharmacokinetics of clopidogrel and its metabolites in patients suffered from cardiovascular diseases. Journal of Medical Science. 83, 3 (Sep. 2014), 215–221. DOI:https://doi.org/10.20883/medical.e70.